• BIO-UV reaffirmed its 2026 revenue target of EUR 38-42 million, implying EUR 18-22 million in second-half revenue versus EUR 15.5 million in H2 2025.
• H1 revenue totaled EUR 20.1 million, down 1% from EUR 20.4 million, with Services and After-Sales up 10% to EUR 7.5 million.
• Solutions returned to growth, rising 4% to EUR 5.4 million, while Products fell 13% to EUR 7.2 million amid sales reorganization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-UV Group SA published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.